New boss brings diagnostic edge to PEB

New boss brings diagnostic edge to PEB
Peter Meintjes has experience in the global molecular diagnostics sectors relevant to Pacific Edge’s Cxbladder products. (Image: Supplied)
Dan Brunskill
Pacific Edge has appointed a molecular diagnostics expert to lead the cancer diagnostics company after the retirement of long-serving chief executive David Darling.The new CEO, Peter Meintjes, has a PhD in biological sciences from Auckland University and has been chief commercial officer of US-based organ transplant testing company Eurofins Transplant Genomics.Prior to that he served as chief executive of Hungary-based Omixon, another global molecular diagnostics company focused on organ and recipient compatibility testing.Pacific Edge said whi...

More Markets

NZ sharemarket claws back to end the week up 0.5%
Markets Market close

NZ sharemarket claws back to end the week up 0.5%

Index rumours drive prices on two shares. 

Graham Skellern 13 Dec 2024
Staff leave Meridian after retail 'reset'
Markets

Staff leave Meridian after retail 'reset'

Expect a very different approach from Meridian in 2025, executive says.

John Anthony 13 Dec 2024
NZX, NZSA want level playing field in climate reporting
Markets

NZX, NZSA want level playing field in climate reporting

Climate reporting liabilities for company directors could soon be eased.

Greg Hurrell 13 Dec 2024
Cannasouth delisting keeps Petterson in charge
Markets

Cannasouth delisting keeps Petterson in charge

Cannasouth major shareholders pushed to end voluntary administration they had called in.

Garth Bray 13 Dec 2024